Additionally, another study examined ANXA1 in breast cancer found that ANXA1, could bind to NEMO at a high level, thereby stabilizing the IKK complex and ultimately inducing the activity of NF-κB (Bist et al., 2011). Here, NFKB1 is linked to breast carcinoma.